Medical Health Cluster


Posthospitalization VTE Prophylaxis for Some Patients with COVID-19

Low-dose rivaroxaban at discharge prevented some venous thromboembolism events at 1 month for high-risk patients. Therapeutic anticoagulation after hospital discharge does not benefit moderate-risk patients recovering from COVID-19 (NEJM JW Gen Med Aug 1 2021 and Lancet 2021; 397:2253), but whether high-risk patients might benefit is unclear. Brazilian investigators enrolled 320 patients (from […]

Read More